Navigation Links
Poniard Pharmaceuticals to Present at the BIO CEO & Investor Conference
Date:2/3/2009

SOUTH SAN FRANCISCO, Calif., Feb. 3 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, today announced that Jerry McMahon, Ph.D., chairman and CEO, will present at the 11th Annual BIO CEO & Investor Conference 2009 on Tuesday, February 10, at 10 a.m. Eastern Time at the Waldorf-Astoria in New York.

Dr. McMahon will provide a corporate overview, including a discussion of the clinical development program for picoplatin, the Company's lead product candidate.

A live audio webcast of the presentation will be available for 10 business days on the "Events" page of the "News & Events" section of the Company's website at http://www.poniard.com.

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc., is a biopharmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer. Picoplatin, the Company's lead platform product candidate, is a new generation platinum chemotherapy. To date, clinical studies suggest that picoplatin has an improved safety profile relative to existing platinum-based cancer therapies. Picoplatin is designed to overcome platinum resistance associated with chemotherapy in solid tumors, and is being studied in multiple cancer indications, combinations and formulations. Clinical trials of intravenous picoplatin include a Phase 3 trial in small cell lung cancer and Phase 2 trials in metastatic colorectal and castration resistant prostate cancers (also known as hormone refractory prostate cancer), as well as a clinical trial of oral picoplatin in solid tumors. For additional information please visit h
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Poniard Pharmaceuticals Announces Positive Tumor Response and Neuropathy Data from Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer
2. Poniard Pharmaceuticals to Present Data from Phase 2 Clinical Trials of Picoplatin in Colorectal and Prostate Cancers
3. Poniard Pharmaceuticals Announces Commercial Supply Agreement for Picoplatin
4. Poniard Pharmaceuticals to Host Third Quarter 2008 Financial Results Conference Call on October 30
5. Poniard Announces Positive Incremental Efficacy and Safety Data from Phase 2 Picoplatin Trial in Patients With Metastatic Colorectal Cancer
6. Poniard Announces Positive Incremental Efficacy and Safety Data From Ongoing Phase 2 Picoplatin Trial in Hormone-Refractory Prostate Cancer
7. Poniard Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
8. Poniard Pharmaceuticals Announces Upcoming Conference Participation
9. Poniard Pharmaceuticals to Present at the 4th Annual Moores UCSD Cancer Center Translational Oncology Symposium
10. Poniard Pharmaceuticals Announces Upcoming Conference Participation
11. Poniard Pharmaceuticals to Host Second Quarter 2008 Financial Results Conference Call on July 31
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 2014 “We are honored to be ... Ven Thangaraj, CEO of Radiant Sage. “We are offering ... the imaging corelab market to a different level. ... organizations to efficiently and effectively manage the massive amounts ... be analyzed and read by trained physicians. Being recognized ...
(Date:8/27/2014)... , Aug. 27, 2014 Research and ... "Global Enzyme for Pulp & Paper Industry Report 2014" ... Global Enzyme for Pulp & Paper Industry Report 2014 ... state of the global enzyme for pulp & paper ... of the industry including definitions, classifications, applications and industry ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Riviera ... is announcing the creation of the Sancilio Scientific ... take the SCI’s philosophy of looking to nature ... and development actions are based on sound scientific ... Scientific Advisory Board provides a vehicle for SCI ...
(Date:8/27/2014)... August 27, 2014 Remcom announces an ... with new features for the biomedical industry. The ... Biological Thermal Sensor, exclusive to the Bio-Pro version of ... of XFdtd, developed to calculate the biological effects of ... been added to all versions to expand engineers’ post-processing ...
Breaking Biology Technology:Radiant Sage Named to CIOReview List of 100 Most Promising Technology Companies 2Global Enzyme for Pulp & Paper Industry Report 2014 2New Sancilio & Company, Inc. Scientific Board 2New Sancilio & Company, Inc. Scientific Board 3Remcom Announces Enhanced Biological Thermal Sensor and Other Biomedical Features in XFdtd EM Simulation Software Update 2Remcom Announces Enhanced Biological Thermal Sensor and Other Biomedical Features in XFdtd EM Simulation Software Update 3
... increases its science and technology (S&T) investment in unmanned ... including autonomy and littoral operations, ONR,s director of innovation ... "We are tackling those issues to find the ... Dr. Larry Schuette, ONR,s director of innovation, at AUVSI,s ...
... Southampton researchers have developed new nano-structured glass, turning it ... in optical manipulation and will significantly reduce the cost ... polarized optical vortex converter created by femtosecond laser nanostructuring ... a team led by Professor Peter Kazansky at the ...
... WOBURN, Mass., Aug. 18, 2011 CBI is pleased ... Annual Registries and Post-Approval Studies Congress, being held September ... REGISTRAT-MAPI, boasts an impressive speaker lineup from Celgene, Covidien, ... and many more. Attendees have the ...
Cached Biology Technology:Office of Naval Research taking on challenges of unmanned underwater vehicles 2New nanostructured glass for imaging and recording 2FDA, NIH to Speak at CBI's 14th Annual Registries and Post-Approval Studies Congress 2
(Date:8/27/2014)... Orange, NJ. August 27, 2014. Using functional near ... differential brain activation patterns between people with multiple ... first MS study in which brain activation was ... task. The article, "Neuroimaging and cognition using functional ... published online on June 11 by Brain ...
(Date:8/27/2014)... it only requires nerve cells to rearrange existing patterns ... generate new patterns, a study of monkeys has found. ... recordings of electrical activity of brain cell networks. The ... Health. , "We looked into the brain and may ... the box," said Aaron Batista, Ph.D., an assistant professor ...
(Date:8/27/2014)... carefully to someone, the first thing we do is ... moving altogether. This strategy helps us hear better by ... This interplay between movement and hearing also has a ... long suggested that the brain,s motor cortex, which controls ... to our conscious perception of sound. , A new ...
Breaking Biology News(10 mins):Kessler Foundation researchers publish first study of brain activation in MS using fNIRS 2Scientists plug into a learning brain 2Scientists plug into a learning brain 3Stop and listen: Study shows how movement affects hearing 2Stop and listen: Study shows how movement affects hearing 3
... and squishing microalgae in a pressure-cooker can fast-forward the ... of Michigan professors are working to understand and improve ... of affordable biofuels that could replace fossil fuels and ... possibility of other new fuel sources such as E. ...
... way to simplify lab-on-a-chip devices that could offer ... of Michigan researchers have created microfluidic integrated circuits. ... flow of electricity on computer chips without external ... fluid through their devices without instructions from outside ...
... 2010 Tel Aviv University President Professor, ... together a myriad of seemingly unrelated chemical reactions creating a ... Chemistry on April 18 , contributes to our understanding ... motion of molecules or other particles within that medium, determining ...
Cached Biology News:Pressure-cooking algae into a better biofuel 2Microfluidic integrated circuit could help enable home diagnostic tests 2Microfluidic integrated circuit could help enable home diagnostic tests 3Tel Aviv University President Co-authors Important Paper Unraveling the Effect of Spatial Organization on Intracellular Chemistry 2Tel Aviv University President Co-authors Important Paper Unraveling the Effect of Spatial Organization on Intracellular Chemistry 3
... in heart tissues, and is produced ... conditions. Treatment of cells with ... TIMP-4 in some cell types, but ... require concentration of cell culture media ...
Goat polyclonal to HSPC150 ( Abpromise for all tested applications). entrezGeneID: 29089...
Anti-MMP-13 Collagenase-3, amino terminal end of active enzyme; rabbit host...
...
Biology Products: